Mr. Huri Aaron Kushner, LMSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 53435 Grand River Ave, New Hudson, MI 48165 Phone: 810-494-7180 Fax: 810-215-1334 |
Ms. Kristin Lee Frederick, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 55919 Pontiac Trail Ct, New Hudson, MI 48165 Phone: 248-361-2925 |
Mrs. Velvet Mosley, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 30154 Magnolia Dr, N/a, New Hudson, MI 48165 Phone: 248-437-5903 |
Nona Maureen Anderson, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 53435 Grand River Ave, New Hudson, MI 48165 Phone: 810-494-7180 Fax: 248-692-4936 |
News Archive
Today, the U.S. Food and Drug Administration approved Rybrevant (amivantamab-vmjw) as the first treatment for adult patients with non-small cell lung cancer whose tumors have specific types of genetic mutations: epidermal growth factor receptor (EGFR) exon 20 insertion mutations.
A national Radiation Therapy Oncology Group (RTOG) study led by a Medical College of Wisconsin Cancer Center physician at Froedtert Hospital in Milwaukee has found that a course of radiation therapy to the brain after treatment for locally advanced non-small cell lung cancer reduced the risk of metastases to the brain within the first year after treatment. The study was presented at the American Society of Clinical Oncology annual meeting in Orlando, June 1.
Boston Scientific Corporation is scheduled to participate in Digestive Disease Week 2013, May 18-21 in Orlando, Fla.
With "meaningful use" a reality, healthcare providers need complete electronic health records. They're quickly learning that to make this happen, they must bring together both electronic data and paper-based content. It's certainly a challenge – one that involves many solutions, not just an electronic medical record like Eclipsys or Cerner.
NIH-supported researchers are reporting additional details about a widely-publicized study that linked a systolic blood pressure target under 120 mm Hg (millimeters of mercury) with reduced cardiovascular disease and a lower risk of death.
› Verified 3 days ago